$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| IMFINZI + LYNPARZA PROLONGED PFS IN ENDOMETRIAL CANCER | 26 May 2023 |
| 25-NSE | 25 May 2023 |
| DIRECTORATE CHANGE | 22 May 2023 |
| TAGRISSO PLUS CHEMO IMPROVED PFS IN LUNG CANCER | 17 May 2023 |
| FARXIGA EXTENDED IN THE US FOR HEART FAILURE | 09 May 2023 |
| DIRECTOR/PDMR SHAREHOLDING | 09 May 2023 |
| TOTAL VOTING RIGHTS | 02 May 2023 |
| ODAC VOTE ON LYNPARZA COMBO IN PROSTATE CANCER | 02 May 2023 |
| DIRECTOR/PDMR SHAREHOLDING | 02 May 2023 |
| 1ST QUARTER RESULTS | 27 Apr 2023 |
| RESULT OF AGM | 27 Apr 2023 |
| FORM 6-K | 27 Apr 2023 |
| BOARD COMMITTEE CHANGES | 27 Apr 2023 |
| DIRECTOR DECLARATION | 26 Apr 2023 |
| UPDATE TO ARRANGEMENTS WITH SOBI AND SANOFI | 11 Apr 2023 |
| LYNPARZA + IMFINZI MET ENDPOINT IN OVARIAN CANCER | 05 Apr 2023 |
| TOTAL VOTING RIGHTS | 03 Apr 2023 |
| ULTOMIRIS RECOMMENDED FOR NMOSD EU APPROVAL | 03 Apr 2023 |
| ASTRAZENECA COMPLETES KYM AGREEMENT FOR CMG901 | 30 Mar 2023 |
| DIRECTOR/PDMR SHAREHOLDING | 27 Mar 2023 |
